Mondaq All Regions - France: Food, Drugs, Healthcare, Life Sciences
Jones Day
The purpose of the pilot phase is to ensure that France is ready when the European Regulation comes into force.
Arnold & Porter Kaye Scholer LLP
On 28 June, the Advocate General of the Court of Justice of the European Union gave his opinion on the SNITEM and Philips France case against France.
Jones Day
French Decree n° 2017-884 of May 9, 2017, was adopted to implement certain provisions of the Legal Ordinance of June 16, 2016, with respect to biomedical research.
Jones Day
Facilities located in France where RMPU is stored on behalf of distribution companies also fall within the scope of the authorization/declaration requirement.
Jones Day
This certification process will replace the current approvals given by the Minister of Health.
Reed Smith (Worldwide)
In France, transparency requirements are regulated by two main sets of laws: "The French Anti-Gift Law" . . .
Reed Smith (Worldwide)
Article body Current Length: 9407 chars Long including spaces Source Preview The relationship between the life sciences industry and health-care practitioners is being reshaped in France through regulatory developments under both the French Anti-Gift Law and the French Sunshine Act.
Jones Day
Titanium dioxide (E 171) is a food additive that is widely used in foods and confectionery as a whitening agent.
Jones Day
The long-awaited decree that clarifies the French "Sunshine" obligations was recently published in the French Official Gazette, and it brings about some important changes...
Jones Day
France's Ministry of Social Affairs and Health issued an instruction notice (document in French) providing for the implementation of the "information systems security plan" for the health care sector.
Reed Smith (Worldwide)
The last version of the "French Bribery Act" gives more shape to the new provisions of the law and confirms that it contemplates to substantially change the legal anti-corruption scope in France.
Jones Day
This tax is an attempt to tackle the increasing overweight problem. A draft decree is under preparation.
Jones Day
On May 19, 2016, the French National Drug and Health Product Authority ("ANSM") posted on its website its first two financial penalty decisions, adopted on May 12, 2016.
Reed Smith (Worldwide)
Billed as a "major step forward for democracy" by the French Minister of Health, the French draft law on ‘health class actions', adopted on 17 December 2015, enters into force on 1 July 2016.
Reed Smith (Worldwide)
In the case at hand, a patient was prescribed Mediator, an appetite suppressant, between 1998 and 2008.
Jones Day
On April 7, 2016, the French National Security Agency for Medicines and Health Products ("ANSM") launched a public consultation on a draft ministerial order setting out pharmacovigilance best practices.
Reed Smith (Worldwide)
We've covered the French Sunshine Act, which requires French pharmaceutical companies to disclose their links to healthcare providers, extensively over the past few years.
Jones Day (French)
Le 28 janvier dernier, le Président du Tribunal de grande instance de Nanterre, statuant en référé, a accordé des dommages et intérêts au titre du préjudice d'anxiété à certaines victimes du Mediator dans trois jugements.
Reed Smith (Worldwide)
On March 17, 2015, a new bill proposal was issued, advocating the creation of a class action procedure for the health sector.
Reed Smith (Worldwide)
Reed Smith’s Global Regulatory Enforcement Law Blog features a post on a recent decision by the French Supreme Administrative Court (Conseil d’Etat) that expands the scope of the French Sunshine Act.
Most Popular Recent Articles
Jones Day
The long-awaited decree that clarifies the French "Sunshine" obligations was recently published in the French Official Gazette, and it brings about some important changes...
Jones Day
This certification process will replace the current approvals given by the Minister of Health.
Jones Day
France's Ministry of Social Affairs and Health issued an instruction notice (document in French) providing for the implementation of the "information systems security plan" for the health care sector.
Arnold & Porter Kaye Scholer LLP
On 28 June, the Advocate General of the Court of Justice of the European Union gave his opinion on the SNITEM and Philips France case against France.
Jones Day
The purpose of the pilot phase is to ensure that France is ready when the European Regulation comes into force.
Jones Day
French Decree n° 2017-884 of May 9, 2017, was adopted to implement certain provisions of the Legal Ordinance of June 16, 2016, with respect to biomedical research.
Jones Day
Facilities located in France where RMPU is stored on behalf of distribution companies also fall within the scope of the authorization/declaration requirement.
Reed Smith (Worldwide)
Billed as a "major step forward for democracy" by the French Minister of Health, the French draft law on ‘health class actions', adopted on 17 December 2015, enters into force on 1 July 2016.
Reed Smith (Worldwide)
We've covered the French Sunshine Act, which requires French pharmaceutical companies to disclose their links to healthcare providers, extensively over the past few years.
Reed Smith (Worldwide)
In the case at hand, a patient was prescribed Mediator, an appetite suppressant, between 1998 and 2008.
Jones Day
On April 7, 2016, the French National Security Agency for Medicines and Health Products ("ANSM") launched a public consultation on a draft ministerial order setting out pharmacovigilance best practices.
Jones Day
On May 19, 2016, the French National Drug and Health Product Authority ("ANSM") posted on its website its first two financial penalty decisions, adopted on May 12, 2016.
Article Search Using Filters
Related Topics
Popular Authors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter